Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Bioresour Technol ; 393: 130120, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38029803

ABSTRACT

Phenol-rich wine grape pomace (WGP) improves the conversion of pig manure (PM) into humic acid (HA) during composting. However, the impact of using combinations of Fe2O3 and biochar known to promote compost maturation remains uncertain. This research explored the individual and combined influence of biochar and Fe2O3 during the co-composting of PM and WGP. The findings revealed that Fe2O3 boosts microbial network symbiosis (3233 links), augments the HA yield to 3.38 by promoting polysaccharide C-O stretching, and improves the germination index to 124.82 %. Limited microbial interactions, increased by biochar, resulted in a lower HA yield (2.50). However, the combination weakened the stretching of aromatics and quinones, which contribute to the formation of HA, resulting in reduced the humification to 2.73. In addition, Bacillus and Actinomadura were identified as pivotal factors affecting HA content. This study highlights Fe2O3 and biochar's roles in phenol-rich compost humification, but combined use reduces efficacy.


Subject(s)
Charcoal , Composting , Vitis , Animals , Swine , Soil , Manure , Humic Substances/analysis , Phenols , Microbial Interactions , Phenol
2.
Bioresour Technol ; 384: 129226, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37270147

ABSTRACT

Copper (Cu) and zinc (Zn) in piglet feed can lead to heavy metals (HMs) accumulation in pig manure (PM). Composting is crucial for recycling biowaste and decreasing HMs bioavailability. This study aimed to investigate the impact of adding wine grape pomace (WGP) on the bioavailability of HMs during PM composting. WGP facilitated the passivation of HMs through Cytophagales and Saccharibacteria_genera_incertae_sedis which promoted the formation of humic acid (HA). Polysaccharide and aliphatic groups in HA dominated the transformation of chemical forms of HMs. Moreover, adding 60% and 40% WGP enhanced the Cu and Zn passivation effects by 47.24% and 25.82%, respectively. Polyphenol conversion rate and core bacteria were identified as key factors in affecting HMs passivation. These results offered new insights into the fate of HMs during PM composting in response to the addition of WGP, which is helpful to practical application of WGP to inactivate HMs for improving compost quality.


Subject(s)
Composting , Metals, Heavy , Vitis , Animals , Swine , Copper , Zinc , Humic Substances , Manure/microbiology , Soil , Metals, Heavy/analysis , Organic Chemicals
3.
PLoS One ; 17(5): e0268262, 2022.
Article in English | MEDLINE | ID: mdl-35522690

ABSTRACT

Bovine mastitis is a common disease occurring in dairy farms and can be caused by more than 150 species of pathogenic bacteria. One of the most common causative organisms is Streptococcus agalactiae, which is also potentially harmful to humans and aquatic animals. At present, research on S. agalactiae in China is mostly concentrated in the northern region, with limited research in the southeastern and southwestern regions. In this study, a total of 313 clinical mastitis samples from large-scale dairy farms in five regions of Sichuan were collected for isolation of S. agalactiae. The epidemiological distribution of S. agalactiae was inferred by serotyping isolates with multiplex polymerase chain reaction. Susceptibility testing and drug resistance genes were detected to guide the clinical use of antibiotics. Virulence genes were also detected to deduce the pathogenicity of S. agalactiae in Sichuan Province. One hundred and five strains of S. agalactiae (33.6%) were isolated according to phenotypic features, biochemical characteristics, and 16S rRNA sequencing. Serotype multiplex polymerase chain reaction analysis showed that all isolates were of type Ia. The isolates were up to 100% sensitive to aminoglycosides (kanamycin, gentamicin, neomycin, and tobramycin), and the resistance rate to ß-lactams (penicillin, amoxicillin, ceftazidime, and piperacillin) was up to 98.1%. The TEM gene (ß-lactam-resistant) was detected in all isolates, which was in accordance with a drug-resistant phenotype. Analysis of virulence genes showed that all isolates harbored the cfb, cylE, fbsA, fbsB, hylB, and α-enolase genes and none harbored bac or lmb. These data could aid in the prevention and control of mastitis and improve our understanding of epidemiological trends in dairy cows infected with S. agalactiae in Sichuan Province.


Subject(s)
Mastitis, Bovine , Streptococcal Infections , Animals , Anti-Bacterial Agents/pharmacology , Cattle , Drug Resistance, Microbial , Female , Humans , Mastitis, Bovine/epidemiology , Mastitis, Bovine/microbiology , Molecular Typing , Prevalence , RNA, Ribosomal, 16S , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcal Infections/veterinary , Streptococcus agalactiae , Virulence/genetics , Virulence Factors/genetics
4.
ACS Appl Mater Interfaces ; 11(30): 26891-26897, 2019 Jul 31.
Article in English | MEDLINE | ID: mdl-31262170

ABSTRACT

We report the development of MOF-derived nitrogen-doped carbon/Co3O4 nanocomposites (Co3O4@NCs) with core-shell structures as an efficient electrocatalyst for the artificial nitrogen fixation at room temperature and atmospheric pressure in 0.05 M H2SO4. It exhibits a high NH3 yield of 42.58 µg h-1 mgcat.-1 and a faradaic efficiency of 8.5% at -0.2 V versus reversible hydrogen electrode. Experimental results show that the great N2 reduction reaction performance of Co3O4@NCs originates from the synergistic effects of N-doped carbon and Co3O4 with significant oxygen vacancy. In addition, we speculate that the core-shell structure can further enhance the electrochemical activity for producing NH3.

5.
Appl Biochem Biotechnol ; 187(1): 310-322, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29943275

ABSTRACT

Grifola frondosa is an edible fungus with a variety of potential pharmacological activities. This study investigates the hypoglycemic, anti-diabetic nephritic, and antioxidant properties of G. frondosa polysaccharides in diet-streptozotocin-induced diabetic rats. After a 4-week treatment with 100 mg/kg of metformin and 200 mg/kg of one of four different G. frondosa polysaccharide mixtures (especially GFPS3 and GFPS4), diabetic rats had enhanced body weight and suppressed plasma glucose, indicating the hypoglycemic activities of the G. frondosa polysaccharides. G. frondosa polysaccharides regulated the level of serum creatinine, blood urea nitrogen, N-acetyl-ß-D-glucosaminidase, and albuminuria; inhibited the serum levels of interleukin (IL)-2, IL-6, and TNF-α; and enhanced the serum levels of matrix metalloproteinase 9 and interferon-α, confirming their anti-diabetic nephritic activities. G. frondosa polysaccharides ameliorated the pathological alterations in the kidneys of diabetic rats. Moreover, G. frondosa polysaccharides modulated the serum levels of oxidant factors such as superoxide dismutase, glutathione peroxidase, catalase, malondialdehyde, and reactive oxygen species, revealing their antioxidant properties. Furthermore, the administration of G. frondosa polysaccharides inhibited nuclear factor kappa B activities in the serum and kidneys. All of the data revealed that the activation of nuclear factor kappa B plays a central role in G. frondosa polysaccharide-mediated anti-diabetic and anti-nephritic activities.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/drug therapy , Functional Food , Grifola/metabolism , Hypoglycemic Agents/therapeutic use , Oxidative Stress/drug effects , Polysaccharides/therapeutic use , Acetylglucosaminidase/metabolism , Animals , Blood Glucose/metabolism , Blood Urea Nitrogen , Catalase/blood , Creatinine/blood , Diet , Diet, High-Fat , Dose-Response Relationship, Drug , Glutathione Peroxidase/blood , Interleukin-2/blood , Interleukin-6/blood , Male , Malondialdehyde/metabolism , NF-kappa B/metabolism , Polysaccharides/administration & dosage , Polysaccharides/pharmacology , Rats, Wistar , Reactive Oxygen Species/metabolism , Streptozocin , Superoxide Dismutase/blood , Tumor Necrosis Factor-alpha/blood
6.
Mol Med Rep ; 16(4): 5533-5540, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28849165

ABSTRACT

The present study successfully demonstrated the neuroprotective effects of purified Lycium barbarum polysaccharide (LBPS02) against glutamate (L­Glu)­induced differentiated PC12 (DPC12) cell apoptosis. Purified polysaccharide was obtained by using a diethylaminoethyl­52 cellulose anion exchange column and a Sepharose G­100 column. During identification and characterization, LBPS02 was validated to be a fraction with 68 kDa molecular weight, and with a structure containing 1→3, 1→4 and 1→6 linkages. Data further revealed that LBPS02 pretreatment effectively improved cell viability, reduced apoptosis rate, and restored the mitochondrial dysfunction in L­Glu­exposed cells. LBPS02 suppressed L­Glu­induced reactive oxygen species (ROS accumulation in DPC12 cells. N­acetylcysteine, a ROS inhibitor, strongly enhanced the efficacy of LBPS02. Furthermore, LBPS02 normalized the levels of anti­apoptotic proteins, and regulated the phosphorylation of extracellular signal­regulated kinases (ERKs) and protein kinase B (Akt) in L­Glu­explored DPC12 cells. In conclusion, LBPS02­mediated neuroprotective effects are at least partially associated with the modulation of Akt and ERKs, and the subsequent inhibition of the mitochondrial apoptotic pathway. LBPS02 may be a candidate for neurodegenerative disease treatment.


Subject(s)
Glutamic Acid/pharmacology , Lycium/chemistry , Mitochondria/drug effects , Mitochondria/metabolism , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Polysaccharides/pharmacology , Signal Transduction/drug effects , Animals , Apoptosis/drug effects , Caspase 3/metabolism , Cell Survival/drug effects , Cells, Cultured , Glutamic Acid/toxicity , Neuroprotective Agents/chemistry , Neuroprotective Agents/isolation & purification , PC12 Cells , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Polysaccharides/chemistry , Polysaccharides/isolation & purification , Rats , Reactive Oxygen Species/metabolism
7.
Appl Biochem Biotechnol ; 182(3): 944-955, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28058588

ABSTRACT

Zeaxanthin (ZA), an important compound found in Lycium barbarum, shows various pharmacodynamic effects. In our present study, a high-fat, high-sucrose diet and streptozotocin (STZ)-induced diabetic rat model was used to investigate the antidiabetic activities of ZA. After a 4-week administration of 200 and 400 mg/kg of ZA and 100 mg/kg of metformin hydrochloride, various blood biochemical indexes were detected. ZA strongly normalized the reduced bodyweight and enhanced fasting blood glucose in diabetic rats. The positive data obtained from the oral glucose tolerance test further confirmed its antidiabetic effects. ZA displayed significant hypolipidemic activities indicated by its modulation of serum levels of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and total cholesterol. The antidiabetic nephropathy of ZA was confirmed by its regulation of pathological kidney structures, urine levels of n-acetyl-ß-d-glucosaminidase and albuminuria, and serum levels of urea nitrogen. ZA inhibited the serum levels of inflammatory factors including interleukin-2 (IL-2), IL-6, tumor necrosis factor-α, and nuclear factor kappa B, further confirming its renal protection. Moreover, the serum imbalances in superoxide dismutase, glutathione peroxidase, methane dicarboxylic aldehyde, and catalase were normalized by ZA, suggesting its antioxidant properties. Altogether, ZA produced hypoglycemic, hypolipidemic, and antidiabetic nephritic effects in a diet-STZ-induced diabetic rat model.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/drug therapy , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Zeaxanthins/pharmacology , Animals , Cytokines/blood , Diabetes Mellitus, Experimental/blood , Diabetic Nephropathies/blood , Lipids/blood , Male , Oxidoreductases/blood , Rats , Rats, Sprague-Dawley
8.
Diabetol Metab Syndr ; 8: 83, 2016.
Article in English | MEDLINE | ID: mdl-28035243

ABSTRACT

OBJECTIVE: Vascular calcification is a significant predictor of coronary heart disease events, stroke, and lower-limb amputation. Advanced glycation end-products (AGEs) play a key role in the development of vascular calcification. However, the role of Nε-carboxymethyl-lysine (CML), a major active ingredient of heterogeneous AGEs, in the development of atherosclerotic calcification in diabetic patients and the underlying mechanism remain unclear. Hence, the role and the mechanism of CML in the transmission pathway of diabetic calcification cascade were investigated in the present study. METHODS: In vivo and in vitro investigations were performed. In study I, 45 diabetic patients hospitalized for above-knee amputation in the Department of Orthopedics, Affiliated Hospital of Jiangsu University were recruited from February 2010 to June 2015. The patients were categorized based on the severity of anterior tibial artery stenosis, which was assessed by color Doppler ultrasound, into mild stenosis (0% < stenosis < 50%, n = 15), moderate stenosis (50 ≤ stenosis < 70%, n = 15), and severe stenosis/occlusion groups (70 ≤ stenosis ≤ 100%, n = 15). In study II, the specific mechanism of CML in the transmission pathway of the diabetic calcification cascade signal was investigated in A7r5 aortic smooth muscle cells under high-lipid, apoptosis-coexisting conditions. ELISA (for serum CML concentration of patients), ultrasound (for plaque size, calcification, blood flow filling, vascular stenosis etc.), H&E staining (for plaque morphology), vonKossa staining (for qualitative analysis of calcification), calcium content assay (for quantitative analysis of calcification), and Western blot analyses of CML, receptor for advanced glycation end products (RAGE), NADPH oxidase 4, phosphorylated p38, core-binding factor α1 (cbfα1), alkaline phosphatase (ALP) and ß-actin were then performed. RESULTS: Morphological analysis revealed extensive calcification lesions in the intima and media of the anterior tibial artery. The extent and area of calcium deposition in the intima significantly increased with disease progression. Interestingly, spotty calcification was predominant in the atherosclerotic plaques of diabetic patients with amputation, and macrocalcification was almost invisible. Pearson correlation analysis revealed that serum CML level exhibited a significant positive correlation with calcium content in the arterial wall (R2 = 0.6141, P < 0.0001). Semi-quantitative Western blot analysis suggested that the intensity of CML/RAGE signal increased with progression of atherosclerotic calcification in diabetic patients. In subsequent in vitro study, the related pathway was blocked by anti-RAGE antibody, NADPH oxidase inhibitor DPI, p38MAPK inhibitor SB203580, and anti-cbfa1 antibody in a step-wise manner to observe changes in calcium deposition and molecular signals. Results suggested that CML may play a key role in atherosclerotic calcification mainly through the CML/RAGE- reactive oxygen species (ROS)-p38MAPK-cbfα1-ALP pathway. CONCLUSION: Spotty calcification was predominant in the atherosclerotic plaques of amputated diabetic patients. CML/RAGE signal may induce the calcification cascade in diabetes via ROS-p38MAPK.

9.
Oxid Med Cell Longev ; 2016: 5893064, 2016.
Article in English | MEDLINE | ID: mdl-27379177

ABSTRACT

Heart failure is a major public health problem especially in the aging population (≥65 years old), affecting nearly 5 million Americans and 15 million European people. Effective management of heart failure (HF) depends on a correct and rapid diagnosis. Presently, BNP (brain natriuretic peptide) or N-terminal pro-brain natriuretic peptide (NT-proBNP) assay is generally accepted by the international community for diagnostic evaluation and risk stratification of patients with HF. However, regardless of its widespread clinical use, BNP is still encumbered by reduced specificity. As a result, diagnosis of heart failure remains challenging. Although significant improvement happened in the clinical management of HF over the last 2 decades, traditional treatments are ultimately ineffective in many patients who progress to advanced HF. Therefore, a novel diagnostic, prognostic biomarker and new therapeutic approach are required for clinical management of HF patients. Circulating miRNAs seem to be the right choice for novel noninvasive biomarkers as well as new treatment strategies for HF. In this review, we briefly discuss the diagnostic, prognostic, and therapeutic role of circulating miRNAs in heart failure patients. We also mentioned our own technique of extraction of RNA and detection of circulating miRNAs from human plasma and oxidative stress associated miRNAs with HF.


Subject(s)
Heart Failure/diagnosis , Heart Failure/pathology , MicroRNAs/blood , MicroRNAs/therapeutic use , Oxidative Stress , Biomarkers/blood , Humans , MicroRNAs/isolation & purification , Prognosis
10.
Biomed Res Int ; 2016: 3140290, 2016.
Article in English | MEDLINE | ID: mdl-27200371

ABSTRACT

Lycium barbarum, extensively utilized as a medicinal plant in China for years, exhibits antitumor, immunoregulative, hepatoprotective, and neuroprotective properties. The present study aims to investigate the hyperglycemic and antidiabetic nephritic effects of polysaccharide which is separated from Lycium barbarum (LBPS) in high-fat diet-streptozotocin- (STZ-) induced rat models. The reduced bodyweight and enhanced blood glucose concentration in serum were observed in diabetic rats, and they were significantly normalized to the healthy level by 100 mg/kg of metformin (Met) and LBPS at doses of 100, 250, and 500 mg/kg. LBPS inhibited albuminuria and blood urea nitrogen concentration and serum levels of inflammatory factors including IL-2, IL-6, TNF-α, IFN-α, MCP-1, and ICAM-1 compared with diabetic rats, and it indicates the protection on renal damage. Furthermore, the activities of SOD and GSH-Px in serum were enhanced strikingly by LBPS which suggests its antioxidation effects. LBPS, compared with nontreated diabetic rats, inhibited the expression of phosphor-nuclear factors kappa B (NF-κB) and inhibitor kappa B alpha in kidney tissues. Collectively, LBPS possesses antidiabetic and antinephritic effects related to NF-κB-mediated antioxidant and antiinflammatory activities.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/immunology , Diabetic Nephropathies/drug therapy , Diabetic Nephropathies/immunology , Drugs, Chinese Herbal/administration & dosage , NF-kappa B/immunology , Animals , Anti-Inflammatory Agents/administration & dosage , Blood Glucose/immunology , Cytokines/blood , Diabetes Mellitus, Experimental/diagnosis , Diabetic Nephropathies/diagnosis , Dietary Fats , Dose-Response Relationship, Drug , Drug Synergism , Male , Metformin/administration & dosage , Rats , Rats, Sprague-Dawley , Renal Agents/administration & dosage , Streptozocin , Treatment Outcome , Urea/blood
11.
Heart Vessels ; 29(5): 679-89, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24141989

ABSTRACT

Angiogenesis plays an important role in myocardial infarction. Apelin and its natural receptor (angiotensin II receptor-like 1, AGTRL-1 or APLNR) induce sprouting of endothelial cells in an autocrine or paracrine manner. The aim of this study is to investigate whether apelin can improve the cardiac function after myocardial infarction by increasing angiogenesis in infarcted myocardium. Left ventricular end-diastolic pressure (LVEDP), left ventricular end systolic pressure (LVESP), left ventricular developed pressure (LVDP), maximal left ventricular pressure development (±LVdp/dtmax), infarct size, and angiogenesis were evaluated to analyze the cardioprotective effects of apelin on ischemic myocardium. Assays of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-bromo-2'-deoxyuridine incorporation, wound healing, transwells, and tube formation were used to detect the effects of apelin on proliferation, migration, and chemotaxis of cardiac microvascular endothelial cells. Fluorescein isothiocyanate-labeled bovine serum albumin penetrating through monolayered cardiac microvascular endothelial cells was measured to evaluate the effects of apelin on permeability of microvascular endothelial cells. In vivo results showed that apelin increased ±LV dp/dtmax and LVESP values, decreased LVEDP values (all p < 0.05), and promoted angiogenesis in rat heart after ligation of the left anterior descending coronary artery. In vitro results showed that apelin dose-dependently enhanced proliferation, migration, chemotaxis, and tube formation, but not permeability of cardiac microvascular endothelial cells. Apelin also increased the expression of vascular endothelial growth factor receptors-2 (VEGFR2) and the endothelium-specific receptor tyrosine kinase (Tie-2) in cardiac microvascular endothelial cells. These results indicated that apelin played a protective role in myocardial infarction through promoting angiogenesis and decreasing permeability of microvascular endothelial cells via upregulating the expression of VEGFR2 and Tie-2 in cardiac microvascular endothelial cells.


Subject(s)
Angiogenesis Inducing Agents/pharmacology , Cardiotonic Agents/pharmacology , Intercellular Signaling Peptides and Proteins/pharmacology , Myocardial Infarction/drug therapy , Neovascularization, Physiologic/drug effects , Animals , Capillary Permeability/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Chemotaxis/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Male , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/metabolism , Myocardium/pathology , Rats, Wistar , Receptor, TIE-2/drug effects , Receptor, TIE-2/metabolism , Recovery of Function , Time Factors , Vascular Endothelial Growth Factor Receptor-2/drug effects , Vascular Endothelial Growth Factor Receptor-2/metabolism , Ventricular Function, Left/drug effects , Ventricular Pressure/drug effects
12.
PLoS One ; 8(4): e60457, 2013.
Article in English | MEDLINE | ID: mdl-23577111

ABSTRACT

Angiogenesis, increased glomerular permeability, and albuminuria are thought to contribute to the progression of diabetic nephropathy (DN). Apelin receptor (APLNR) and the endogenous ligand of APLNR, apelin, induce the sprouting of endothelial cells in an autocrine or paracrine manner, which may be one of the mechanisms of DN. The aim of this study was to investigate the role of apelin in the pathogenesis of DN. Therefore, we observed apelin/APLNR expression in kidneys from patients with type 2 diabetes as well as the correlation between albuminuria and serum apelin in patients with type 2 diabetes. We also measured the proliferating, migrating, and chemotactic effects of apelin on glomerular endothelial cells. To measure the permeability of apelin in glomerular endothelial cells, we used transwells to detect FITC-BSA penetration through monolayered glomerular endothelial cells. The results showed that serum apelin was significantly higher in the patients with type 2 diabetes compared to healthy people (p<0.05, Fig. 1B) and that urinary albumin was positively correlated with serum apelin (R = 0.78, p<0.05). Apelin enhanced the migration, proliferation, and chemotaxis of glomerular endothelial cells in a dose-dependent manner (p<0.05). Apelin also promoted the permeability of glomerular endothelial cells (p<0.05) and upregulated the expression of VEGFR2 and Tie2 in glomerular endothelial cells (p<0.05). These results indicated that upregulated apelin in type 2 diabetes, which may be attributed to increased fat mass, promotes angiogenesis in glomeruli to form abnormal vessels and that enhanced apelin increases permeability via upregulating the expression of VEGFR2 and Tie2 in glomerular endothelial cells.


Subject(s)
Adipokines/metabolism , Diabetic Nephropathies/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Albuminuria/complications , Animals , Apelin , Apelin Receptors , Cell Movement , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/complications , Diabetic Nephropathies/genetics , Diabetic Nephropathies/pathology , Endothelial Cells/metabolism , Endothelial Cells/pathology , Female , Humans , Kidney Glomerulus/pathology , Male , Mice , Middle Aged , Permeability , Receptor, TIE-2/metabolism , Receptors, G-Protein-Coupled/genetics , Up-Regulation , Vascular Endothelial Growth Factor Receptor-2/metabolism
13.
Cytokine ; 56(2): 188-91, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21763153

ABSTRACT

BACKGROUND: Acute coronary syndrome (ACS) is one of the most common forms of heart disease. Recent studies have shown that interleukin (IL)-8 plays a key role in the development of atherosclerotic plaques, but the relationship between the common genetic variants of IL-8 and ACS has not been extensively studied. METHODS: This case-control study in the Chinese Han population included 675 patients with ACS and 636 age- and sex-matched controls. We investigated IL-8 polymorphisms and their association with susceptibility to ACS. The investigation was replicated in the second study comprising 360 cases and 360 control subjects. The plasma concentration of IL-8 was measured by enzyme-linked immunosorbent assay. RESULTS: IL-8 -251 A/T polymorphism was associated with increased susceptibility to ACS (P=0.004; odds ratio=1.30; 95% confidence interval: 1.12-1.53). The second study yielded similar results. An increased IL-8 level was found in the plasma of acute myocardial infarction patients, suggesting that IL-8 -251 A/T may affect the expression of IL-8. CONCLUSION: IL-8 -251 A/T polymorphism is associated with ACS risk in the Chinese Han population and the A allele of IL-8 -251 A/T may be an independent predictive factor for ACS.


Subject(s)
Acute Coronary Syndrome/genetics , Ethnicity , Interleukin-8/genetics , Polymorphism, Single Nucleotide , Acute Coronary Syndrome/ethnology , Aged , Base Sequence , Case-Control Studies , China , DNA Primers , Female , Humans , Interleukin-8/blood , Male , Middle Aged , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...